These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The impact of inhaled corticosteroid and long-acting beta-agonist combination therapy on outcomes in COPD. Hanania NA. Pulm Pharmacol Ther; 2008; 21(3):540-50. PubMed ID: 18280761 [Abstract] [Full Text] [Related]
3. Comparing a fixed combination of budesonide/formoterol with other inhaled corticosteroid plus long-acting beta-agonist combinations in patients with chronic obstructive pulmonary disease: a review. Solidoro P, Patrucco F, Bagnasco D. Expert Rev Respir Med; 2019 Nov; 13(11):1087-1094. PubMed ID: 31498714 [Abstract] [Full Text] [Related]
4. Differences in the efficacy and safety among inhaled corticosteroids (ICS)/long-acting beta2-agonists (LABA) combinations in the treatment of chronic obstructive pulmonary disease (COPD): Role of ICS. Latorre M, Novelli F, Vagaggini B, Braido F, Papi A, Sanduzzi A, Santus P, Scichilone N, Paggiaro P. Pulm Pharmacol Ther; 2015 Feb; 30():44-50. PubMed ID: 25445928 [Abstract] [Full Text] [Related]
6. A re-evaluation of the role of inhaled corticosteroids in the management of patients with chronic obstructive pulmonary disease. D'Urzo A, Donohue JF, Kardos P, Miravitlles M, Price D. Expert Opin Pharmacother; 2015 Feb; 16(12):1845-60. PubMed ID: 26194213 [Abstract] [Full Text] [Related]
10. LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes. Hizawa N. Int J Chron Obstruct Pulmon Dis; 2015 Feb; 10():1093-102. PubMed ID: 26089659 [Abstract] [Full Text] [Related]
11. Combination of budesonide/formoterol more effective than fluticasone/salmeterol in preventing exacerbations in chronic obstructive pulmonary disease: the PATHOS study. Larsson K, Janson C, Lisspers K, Jørgensen L, Stratelis G, Telg G, Ställberg B, Johansson G. J Intern Med; 2013 Jun; 273(6):584-94. PubMed ID: 23495860 [Abstract] [Full Text] [Related]
19. Advances in drug delivery: Is triple therapy the future for the treatment of chronic obstructive pulmonary disease? Salama RO, Young PM, Rogueda P, Lallement A, Iliev I, Traini D. Expert Opin Pharmacother; 2011 Aug; 12(12):1913-32. PubMed ID: 21714776 [Abstract] [Full Text] [Related]
20. Corticosteroids and adrenoceptor agonists: the compliments for combination therapy in chronic airways diseases. Sin DD, Man SF. Eur J Pharmacol; 2006 Mar 08; 533(1-3):28-35. PubMed ID: 16457807 [Abstract] [Full Text] [Related] Page: [Next] [New Search]